No Data
SymbolStock Name
Latest PriceChg%ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D %Chg10D %Chg20D %Chg60D % Chg120D %Chg250D %Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
US OptionsDetailed Quotes
DYN240816C45000
- 1.50
- -0.70-31.82%
15min DelayTrading Jul 22 14:30 ET
1.50High1.50Low
1.50Open2.20Pre Close6 Volume11 Open Interest45.00Strike Price900.00Turnover57.96%IV7.99%PremiumAug 16, 2024Expiry Date0.00Intrinsic Value100Multiplier25DDays to Expiry1.50Extrinsic Value100Contract SizeAmericanOptions Type0.4314Delta0.0596Gamma22.37Leverage Ratio-0.0539Theta0.0116Rho9.65Eff Leverage0.0447Vega
Intraday
- 5D
- Daily
News
What Makes Dyne Therapeutics, Inc. (DYN) a Strong Momentum Stock: Buy Now?
XPeng & QuantumScape Are Among Top 11 Mid Cap Stocks That Performed Well Last Week (July 7-July 13): Details
These ten mid-cap stocks were the best performers in the last week. Are they in your portfolio?QuantumScape Corporation (NYSE:QS) stock jumped 64.34% after the company announced it entered into an
Express News | Dyne Therapeutics Shares Are Trading Higher After JP Morgan Maintained an Overweight Rating on the Stock and Raised Its Price Target From $39 to $43
Dyne Therapeutics Is Maintained at Overweight by JP Morgan
Dyne Therapeutics Is Maintained at Overweight by JP
Dyne Therapeutics Price Target Raised to $43.00/Share From $39.00 by JP Morgan
Dyne Therapeutics Price Target Raised to $43.00/Share From $39.00 by JP
JPMorgan Adjusts Price Target on Dyne Therapeutics to $43 From $39, Maintains Overweight Rating
Dyne Therapeutics (DYN) has an average buy rating and a price target range of $41 to $56, according to analysts polled by Capital IQ.Price: 34.46, Change: +0.84, Percent Change: +2.51
Comments
These ten mid-cap stocks were the best performers in the last week. Are they in your portfolio? ![]()
$XPeng(XPEV.US$ stock rose 15.56%. Shares of Chinese stocks gained following an increase in China's June exports.
$QuantumScape(QS.US$ stock jumped 64.34% after the company announced it entered into an agreement with Volkswagen $VOLKSWAGEN A G(VWAGY.US$ 's battery company PowerC...
$XPeng(XPEV.US$ stock rose 15.56%. Shares of Chinese stocks gained following an increase in China's June exports.
$QuantumScape(QS.US$ stock jumped 64.34% after the company announced it entered into an agreement with Volkswagen $VOLKSWAGEN A G(VWAGY.US$ 's battery company PowerC...
2
$Dyne Therapeutics(DYN.US$ Dyne Therapeutics Announces New Clinical Data From ACHIEVE Trial of DYNE-101 in DM1 and DELIVER Trial of DYNE-251 in DMD Demonstrating Compelling Impact on Key Disease Biomarkers and Improvement in Multiple Functional Endpoints
GlobeNewswire· 7 mins ago
- In Phase 1/2 ACHIEVE Trial, DYNE-101 Demonstrated Dose Dependent 27% Mean Splicing Correction Across All Patients in the 5.4 mg/kg Cohort at 3 Months -
- DYNE-101 Showed Improvement in Myotonia, Muscle Strength, ...
GlobeNewswire· 7 mins ago
- In Phase 1/2 ACHIEVE Trial, DYNE-101 Demonstrated Dose Dependent 27% Mean Splicing Correction Across All Patients in the 5.4 mg/kg Cohort at 3 Months -
- DYNE-101 Showed Improvement in Myotonia, Muscle Strength, ...
4
2
» Holdings: 75
» Holdings in Top 20: 70.21%
» Qtr over Qtr Change**: +21.81%
Top Holdings:
$Ascendis Pharma A/S(ASND.US$
$Vaxcyte(PCVX.US$
$Legend Biotech(LEGN.US$
$Janux Therapeutics(JANX.US$
$Aerovate(AVTE.US$
$Rhythm Pharmaceuticals(RYTM.US$
$Evolent Health(EVH.US$
$NewAmsterdam Pharma(NAMS.US$
$RxSight(RXST.US$
$TYRA BIOSCIENCES, INC.(TYRA.US$
$Edgewise Therapeutics(EWTX.US$
$4D Molecular Therapeutics(FDMT.US$
$Biogen(BIIB.US$
$PepGen(PEPG.US$
...
» Holdings in Top 20: 70.21%
» Qtr over Qtr Change**: +21.81%
Top Holdings:
$Ascendis Pharma A/S(ASND.US$
$Vaxcyte(PCVX.US$
$Legend Biotech(LEGN.US$
$Janux Therapeutics(JANX.US$
$Aerovate(AVTE.US$
$Rhythm Pharmaceuticals(RYTM.US$
$Evolent Health(EVH.US$
$NewAmsterdam Pharma(NAMS.US$
$RxSight(RXST.US$
$TYRA BIOSCIENCES, INC.(TYRA.US$
$Edgewise Therapeutics(EWTX.US$
$4D Molecular Therapeutics(FDMT.US$
$Biogen(BIIB.US$
$PepGen(PEPG.US$
...
7
Read more